CytoSorbents

11/21/2025

⏳Every minute counts in a stroke - but it took decades to prove clot-busting drugs could help.

For decades, stroke was seen as untreatable. Early trials of thrombolysis raised fears of brain bleeding. Many doctors doubted it would ever work.

In 1995, the NINDS trial showed that tPA, given within 3 hours, improved recovery. Yet many hospitals hesitated, worried about risks. Only with specialized Stroke Units, rapid imaging, and strict protocols did thrombolysis become reliable.

Step by step, evidence and experience transformed skepticism into confidence. Today, thrombolysis is routine worldwide.
👉 Proven therapies still need practice and refinement before becoming standard.

has followed a similar path-growing stronger with evidence and experience.
Read more in our blog ‘Every Innovation Has a Learning Curve’, and visit our Literature Database and Voices Around the World for real-life evidence and experience with CytoSorb.

11/21/2025

It is a pleasure to host our Sales Meeting Germany at the CytoSorbents European headquarters in Berlin together with Dr. Phillip P. Chan (CEO), Dr. Christian Steiner (EVP Sales & Marketing, Co-Managing Director CytoSorbents Europe GmbH) and Peter J. Mariani (CFO).

The exchange offered valuable insights into current developments and strengthened the collaboration between our German team and global leadership.
Many thanks to everyone involved for the constructive discussions and the continued commitment that drives our work forward.

11/20/2025

🎥 Watch more voices here: https://cytosorbents.com/voices/

11/19/2025

When women in tech meet purpose in medicine.

At Web Summit 2025 in Lisbon, women from around the world connect to shape the future of technology and healthcare. From AI and digital innovation to real-world impact — it’s about creating space for diverse voices and new ideas. Representing CytoSorbents in this community means bringing our passion for digital transformation to a global stage.

11/18/2025

„Klug entscheiden“ – das Motto des diesjährigen DIVI-Kongresses passt perfekt zu den Herausforderungen unserer Zeit:
Patientenversorgung bedeutet, wissenschaftliche Evidenz mit individuellen Bedürfnissen in Einklang zu bringen.

CytoSorbents unterstützt Ärztinnen und Ärzte weltweit bei dieser täglichen Gratwanderung – mit innovativen Lösungen zur Steuerung schwerer Entzündungsreaktionen.

🤝 Lassen Sie uns auf dem DIVI 2025 in Hamburg ins Gespräch kommen!
👉 https://www.divi25.de/

11/18/2025

CytoSorbents is proud to be part of the ALAP Regional Symposium 2025 in Guatemala City (November 21–22)!

🎤 Don’t miss the session by Dr. Salomón Muralles (Guatemala):
Optimizing hemoadsorption therapies and modulating the inflammatory response in postoperative cardiac surgery.

Two days of knowledge exchange, innovation, and collaboration in perfusion and cardiac care across Latin America. See you in Guatemala! 🇬🇹

11/17/2025

We are honored to be presenting at the Jefferies Global Healthcare Conference in London Tuesday November 18th 7:30amET/12:30pm GMT— one of the premier global events bringing together innovative healthcare companies and leading investors from around the world.

This is a tremendous opportunity to highlight our progress, share our vision, and connect with strategic partners who share our commitment to advancing healthcare.

📅 November 18–19, 2025
📍 London, UK

We look forward to productive discussions, one-on-one meetings, and showcasing the impactful work we’re doing.
https://www.prnewswire.com/news-releases/updated-cytosorbents-to-present-at-the-jefferies-global-healthcare-conference-in-london-302617696.html?tc=eml_cleartime

11/14/2025

https://www.prnewswire.com/news-releases/cytosorbents-reports-third-quarter-2025-financial-results-and-provides-business-update-302614954.html?tc=eml_cleartime

11/14/2025

🌎 World Diabetes Day 🌎

? In July 1921: A Landmark Day in Diabetes Treatment History!
In July 1921, Dr. Frederick Banting and Charles Best achieved a groundbreaking milestone in medical history at the University of Toronto. They successfully isolated insulin for the first time, revolutionizing diabetes treatment forever.

Dr. Banting, a Canadian surgeon, and Best, a medical student, conducted pioneering research on dogs, demonstrating that insulin injections could normalize blood glucose levels in animals with induced diabetes symptoms. This pivotal discovery laid the foundation for insulin therapy in humans. Just months later, on January 11, 1922, 14-year-old Leonard Thompson became the first person to receive insulin treatment. Initially, there were challenges, but with rapid refinement of the insulin extraction process, Thompson's condition improved significantly by January 23.

This marked a monumental shift, turning diabetes from a fatal illness into a manageable condition. The impact of Banting and Best's work was profound and far-reaching. By 1923, insulin was being produced on a large scale, saving countless lives worldwide. Their efforts were duly recognized when Dr. Banting and Professor John Macleod received the in Medicine in 1923. Though Charles Best, who played a crucial role, was not initially included, Banting ensured recognition by sharing the award money with him.

Today, on , we honor their legacy as insulin remains a cornerstone of diabetes treatment, showcasing the power of collaborative research and dedication to improving healthcare globally.

11/14/2025

Strengthening Clinical Evidence with the COSMOS Registry

At CytoSorbents, advancing evidence-based practice in critical care is a core priority. With the COSMOS Registry, we are systematically collecting real-world data from international clinical sites to understand better patient pathways, treatment patterns, and outcomes in hemoadsorption therapy.

To support this effort, we implemented a flexible and compliant Electronic Data Capture system that enables efficient data collection, automated scoring, and transparent study tracking — ensuring high-quality insights to drive future innovation.

This ambitious project reflects our ongoing commitment to scientific rigor, collaboration with leading clinical centers, and continuous improvement in patient care.

Learn more in this Case story from Marvin, Part of EvidentIQ Group
👉 https://xclinical.com/simplifying-complexity-in-clinical-resarch/

How Marvin empowered CytoSorbents with Smarter Data Capture and Reporting CytoSorbents, a pioneer in blood purification for intensive care and cardiac surgery, needed a powerful yet flexible solution to manage the complex data of their international COSMOS Registry. Working closely with us the team....

11/14/2025

Expertenwissen zur korrekten Dokumentation und Kodierung

Freuen Sie sich auf fundiertes Know-how rund um das richtige Dokumentieren und Kodieren im Krankenhausalltag.
Unsere Referenten beleuchten sowohl rechtliche als auch medizinisch-praktische und abrechnungstechnische Fragestellungen – verständlich und anwendungsorientiert.

Wann? 26.11.2025, 15:00 Uhr
Wo? Online 👉 https://cyto.news/medcon/nov2025
Jetzt anmelden und von Expertenwissen profitieren!